Provided by Tiger Fintech (Singapore) Pte. Ltd.

COMPASS Pathways plc

3.54
+0.15504.59%
Volume:1.86M
Turnover:6.59M
Market Cap:327.60M
PE:-1.54
High:3.70
Open:3.42
Low:3.40
Close:3.38
Loading ...

Company Profile

Company Name:
COMPASS Pathways plc
Exchange:
NASDAQ
Establishment Date:
2020
Employees:
166
Office Location:
33 Broadwick Street,London,Greater London,United Kingdom
Zip Code:
W1F 0DQ
Phone:
- -
Fax:
- -
Introduction:
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Directors

Name
Position
George Goldsmith
Chief Executive Officer, Co-Founder and Chairman
Ekaterina Malievskaia
Chief Innovation Officer, Co-Founder and Director
Annalisa Jenkins
Director
David York Norton
Director
Florian Brand
Director
Jason Camm
Director
Linda McGoldrick
Director
Robert McQuade
Director
Thomas Lonngren
Director

Shareholders

Name
Position
George Goldsmith
Chief Executive Officer, Co-Founder and Chairman
Piers Morgan
Chief Financial Officer
Ekaterina Malievskaia
Chief Innovation Officer, Co-Founder and Director
Lars Christian Wilde
President, Chief Business Officer and Co-Founder
Nate Poulsen
General Counsel and Chief Legal Officer